Evidence map›Paper›PMID 27191707›Full record

ReviewVirulence2017

Exploiting mitochondria as targets for the development of new antifungals.

Dongmei Li, Richard Calderone

Abstract readReview
In one paragraph

Review in Virulence, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Antifungal activity of cinnamaldehyde againstFrontiers in microbiology · 2025
    Article
  7. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Disclosing the Antifungal Mechanisms of the Cyclam Salt HInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Journal of fungi (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Review
  18. Exposure ofAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dongmei Lia Department of Microbiology & Immunology , Georgetown University Medical Center , Washington , DC , USA.
Richard Calderonea Department of Microbiology & Immunology , Georgetown University Medical Center , Washington , DC , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria are essential for cell growth and survival of most fungal pathogens. Energy (ATP) produced during oxidation/reduction reactions of the electron transport chain (ETC) Complexes I, III and IV (CI, CIII, CIV) fuel cell synthesis. The mitochondria of fungal pathogens are understudied even though more recent published data suggest critical functional assignments to fungal-specific proteins. Proteins of mammalian mitochondria are grouped into 16 functional categories. In this review, we focus upon 11 proteins from 5 of these categories in fungal pathogens, OXPHOS, protein import, stress response, carbon source metabolism, and fission/fusion morphology. As these proteins also are fungal-specific, we hypothesize that they may be exploited as targets in antifungal drug discovery. We also discuss published transcriptional profiling data of mitochondrial CI subunit protein mutants, in which we advance a novel concept those CI subunit proteins have both shared as well as specific responsibilities for providing ATP to cell processes.

Indexed as

AnimalsAntifungal AgentsDrug DiscoveryElectron Transport Complex IEnergy MetabolismFungal ProteinsFungiGene Expression ProfilingMitochondriaMitochondrial ProteinsAntifungal AgentsElectron Transport Complex IFungal ProteinsMitochondrial Proteinsantifungalscomplex I subunitsdiscoverymitochondriatargets

Identifiers

PMID27191707
PMCPMC5354164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.